FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387186711> ?p ?o ?g. }

• W4387186711 endingPage "6285" @default.
• W4387186711 startingPage "6285" @default.
• W4387186711 abstract "Nonsteroidal mineralocorticoid receptor antagonists (MRAs) present a promising therapeutic option in cardiorenal diseases, mitigating the limitations of steroidal MRAs. Finerenone, a third-generation nonsteroidal MRA, has demonstrated beneficial effects in heart failure (HF) and chronic kidney disease (CKD). Clinical trials, including FIDELIO-DKD and FIGARO-DKD, revealed finerenone's efficacy in improving kidney and cardiovascular (CV) outcomes. Patients with CKD and type 2 diabetes (T2DM) on finerenone experienced reduced rates of cardiovascular events, including hospitalization for HF. However, these trials excluded symptomatic HF patients, focusing on asymptomatic or early-stage HF. The ongoing FINEARTS-HF trial evaluates finerenone in HF with preserved ejection fraction (HFpEF). Additionally, studies exploring finerenone and sodium-glucose cotransporter 2 (SGLT2) inhibitors' (Empagliflozin) combination effects in CKD and T2DM (CONFIDENCE) and the selective MR modulator AZD9977 with another SGLT2 inhibitor (dapagliflozin) in HF and CKD (MIRACLE) aim to expand treatment options. While SGLT-2 inhibitors were shown to reduce hyperkalemia risk in FIDELIO-DKD and potentially lower new-onset HF incidence in FIGARO-DKD, further research is essential. So far, the evidence for the beneficial effect of finerenone in the spectrum of cardiorenal diseases is based only on the results of studies conducted in patients with T2DM, and clinical trials of finerenone in patients with nondiabetic kidney disease are ongoing. Nonsteroidal MRAs hold significant potential as pivotal treatment targets across the cardiorenal disease spectrum. This review will focus on the effects of finerenone on cardiorenal disease." @default.
• W4387186711 created "2023-09-30" @default.
• W4387186711 creator A5006788933 @default.
• W4387186711 creator A5050323987 @default.
• W4387186711 creator A5085606042 @default.
• W4387186711 date "2023-09-29" @default.
• W4387186711 modified "2023-10-17" @default.
• W4387186711 title "Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease" @default.
• W4387186711 cites W1830102405 @default.
• W4387186711 cites W1987089303 @default.
• W4387186711 cites W2019223575 @default.
• W4387186711 cites W2021232559 @default.
• W4387186711 cites W2062266308 @default.
• W4387186711 cites W2079169053 @default.
• W4387186711 cites W2104364870 @default.
• W4387186711 cites W2115443739 @default.
• W4387186711 cites W2138612646 @default.
• W4387186711 cites W2143300626 @default.
• W4387186711 cites W2149030597 @default.
• W4387186711 cites W2152072062 @default.
• W4387186711 cites W2157466080 @default.
• W4387186711 cites W2206859595 @default.
• W4387186711 cites W2323458614 @default.
• W4387186711 cites W2344743510 @default.
• W4387186711 cites W2548675393 @default.
• W4387186711 cites W2611424420 @default.
• W4387186711 cites W2792230432 @default.
• W4387186711 cites W2802909629 @default.
• W4387186711 cites W2897424563 @default.
• W4387186711 cites W2915506231 @default.
• W4387186711 cites W2971967706 @default.
• W4387186711 cites W3041996965 @default.
• W4387186711 cites W3094429645 @default.
• W4387186711 cites W3103813916 @default.
• W4387186711 cites W3107151441 @default.
• W4387186711 cites W3110972804 @default.
• W4387186711 cites W3216608164 @default.
• W4387186711 cites W4205411632 @default.
• W4387186711 cites W4206077470 @default.
• W4387186711 cites W4210964775 @default.
• W4387186711 cites W4214897998 @default.
• W4387186711 cites W4220692009 @default.
• W4387186711 cites W4225655571 @default.
• W4387186711 cites W4226114397 @default.
• W4387186711 cites W4226182345 @default.
• W4387186711 cites W4237773453 @default.
• W4387186711 cites W4282925091 @default.
• W4387186711 cites W4283070467 @default.
• W4387186711 cites W4297463824 @default.
• W4387186711 cites W4304759481 @default.
• W4387186711 cites W4318476398 @default.
• W4387186711 cites W4380354692 @default.
• W4387186711 cites W4382602245 @default.
• W4387186711 cites W4383652763 @default.
• W4387186711 doi "https://doi.org/10.3390/jcm12196285" @default.
• W4387186711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37834929" @default.
• W4387186711 hasPublicationYear "2023" @default.
• W4387186711 type Work @default.
• W4387186711 citedByCount "0" @default.
• W4387186711 crossrefType "journal-article" @default.
• W4387186711 hasAuthorship W4387186711A5006788933 @default.
• W4387186711 hasAuthorship W4387186711A5050323987 @default.
• W4387186711 hasAuthorship W4387186711A5085606042 @default.
• W4387186711 hasBestOaLocation W43871867111 @default.
• W4387186711 hasConcept C126322002 @default.
• W4387186711 hasConcept C134018914 @default.
• W4387186711 hasConcept C164705383 @default.
• W4387186711 hasConcept C177713679 @default.
• W4387186711 hasConcept C189135053 @default.
• W4387186711 hasConcept C2776379505 @default.
• W4387186711 hasConcept C2777180221 @default.
• W4387186711 hasConcept C2778198053 @default.
• W4387186711 hasConcept C2778525890 @default.
• W4387186711 hasConcept C2778653478 @default.
• W4387186711 hasConcept C2779306644 @default.
• W4387186711 hasConcept C2780072264 @default.
• W4387186711 hasConcept C2780152017 @default.
• W4387186711 hasConcept C2781309322 @default.
• W4387186711 hasConcept C555293320 @default.
• W4387186711 hasConcept C71924100 @default.
• W4387186711 hasConceptScore W4387186711C126322002 @default.
• W4387186711 hasConceptScore W4387186711C134018914 @default.
• W4387186711 hasConceptScore W4387186711C164705383 @default.
• W4387186711 hasConceptScore W4387186711C177713679 @default.
• W4387186711 hasConceptScore W4387186711C189135053 @default.
• W4387186711 hasConceptScore W4387186711C2776379505 @default.
• W4387186711 hasConceptScore W4387186711C2777180221 @default.
• W4387186711 hasConceptScore W4387186711C2778198053 @default.
• W4387186711 hasConceptScore W4387186711C2778525890 @default.
• W4387186711 hasConceptScore W4387186711C2778653478 @default.
• W4387186711 hasConceptScore W4387186711C2779306644 @default.
• W4387186711 hasConceptScore W4387186711C2780072264 @default.
• W4387186711 hasConceptScore W4387186711C2780152017 @default.
• W4387186711 hasConceptScore W4387186711C2781309322 @default.
• W4387186711 hasConceptScore W4387186711C555293320 @default.
• W4387186711 hasConceptScore W4387186711C71924100 @default.
• W4387186711 hasIssue "19" @default.
• W4387186711 hasLocation W43871867111 @default.

• next